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Abstract
Requirements about the quality of medical guidelines can be represented using
schemata borrowed from the theory of abductive diagnosis, using temporal logic
to model the time-oriented aspects expressed in a guideline. Previously we have
shown that these requirements can be verified using interactive theorem proving
techniques [HLB04]. In this paper, we investigate how this approach can be mapped
to the facilities of a resolution-based theorem prover, otter, and a complementary
program that searches for finite models of first-order statements, mace-2. It is
shown that the reasoning that is required for checking the quality of a guideline can
be mapped to such fully automated theorem-proving facilities. The medical quality
of an actual guideline concerning diabetes mellitus 2 is investigated in this way.
1 Introduction
Health-care is becoming more and more complicated at an astonishing rate. On the one
hand, the number of different patient management options has risen considerably during
the last couple of decades, whereas, on the other hand, medical doctors are expected
to take decisions balancing benefits for the patient against financial costs. There is
a growing trend within the medical profession to believe that clinical decision-making
should be based as much as possible on sound scientific evidence; this has become
known as evidence-based medicine [Woo00]. Evidence-based medicine has given a major
impetus to the development of guidelines, documents offering a detailed description of
steps that must be taken and considerations that must be taken into account by health-
care professionals in managing a disease in a patient, to avoid substandard practices or
outcomes. Their general aim is to promote standards of medical care.
Researchers in artificial intelligence (AI) have picked up on these developments
[FD00, OMGM98], and some of them, for example in the Asgaard project [SMJ98],
are involved in the design of computer-oriented languages, tools and systems that sup-
port the design and deployment of medical guidelines. AI researchers see guidelines as
∗This work has been partially supported by the European Commission’s IST program, under contract
number IST-FP6-508794 Protocure II.
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good real-world examples of highly structured, systematic documents that are amenable
to formalisation. Previously, it was shown that for reasoning about models of medical
knowledge, for example in the context of medical expert systems [Luc93], automated
reasoning techniques (e.g., [Rob65, WOLB84]) are a practical option.
There are two approaches to checking the quality of medical guidelines: (1) the
object-level approach amounts to translating a guideline to a formal language, such as
Asbru [SMJ98], and next applying techniques from program verification to the resulting
representation in establishing whether certain domain-specific properties hold; (2) the
meta-level approach, which consists of formalising general properties to which a guideline
should comply, and then investigating whether this is the case. Here we are concerned
with the meta-level approach to guideline-quality checking. For example, a good-quality
medical guideline regarding treatment of a disorder should preclude the prescription of
redundant drugs, or advise against the prescription of treatment that is less effective
than some alternative.
Such a meta-level approach corresponds to reasoning that occurs during the process
of designing medical guidelines and therefore such checks could be valuable. The design
of a guideline can be seen as a very complex process where formulation of knowledge
and construction of conclusions and corresponding recommendations are intermingled.
This makes it cumbersome to do interactive verification of hypotheses concerning the
optimal recommendation during the construction of such a guideline, because guide-
line developers do not generally have the necessary background in formal methods to
construct such proofs interactively. Automated theorem proving on a language could
therefore be potentially more useful for supporting the guideline development process.
The goal of the research described here was to establish how feasible it is to imple-
ment such meta-reasoning techniques in existing tools for automated deduction. We will
show that it is indeed possible to explore the route from informal medical knowledge
to a logical formalisation and automated verification. Previously, we have shown that
the theory of abductive diagnosis can be taken as a foundation for the formalisation
of quality criteria of a medical guideline [Luc03] and that these can be verified using
(interactive) program verification techniques [HLB04]. In this paper, we provide an
alternative to this approach by translating this formalism, a restricted part of tempo-
ral logic, to standard first order logic. We will show that, because of the restricted
language we used for the formalisation of the object knowledge, the translation is a
relatively simple fragment of first-order logic and is therefore amenable to automated
reasoning techniques.
The paper is organised as follows. In the next section, we start by explaining what
medical guidelines are, and a method for formalising guidelines by temporal logic is
briefly reviewed. In Section 3 the formalisation of guideline quality using a meta-level
scheme which comes from the theory of abductive diagnosis is described. The guideline
on the management of diabetes mellitus type 2 that has been used in the case study is
given attention in Section 4, and a formalisation of this is given as well. An approach to
checking the quality of this guideline using the deductive machinery offered by otter
and mace-2 is presented in Section 5. Finally, Section 6 discusses what has been
achieved, the advantages and limitations of this approach are brought into perspective
and future research plans are mentioned.
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• Step 1: diet
• Step 2: if Quetelet Index (QI) ≤ 27, prescribe a sulfonylurea drug; otherwise,
prescribe a biguanide drug
• Step 3: combine a sulfonylurea drug and biguanide (replace one of these by a
α-glucosidase inhibitor if side-effects occur)
• Step 4: one of the following:
– oral antidiabetics and insulin
– only insulin
Figure 1: Tiny fragment of a clinical guideline on the management of diabetes mellitus
type 2. If one of the steps k = 1, 2, 3 is ineffective, the management moves to step k+1.
2 Preliminaries
2.1 The Design of Medical Guidelines
The design of a medical guideline is far from easy. Firstly, the gathering and classification
of the scientific evidence underlying and justifying the recommendations mentioned in
a guideline is time consuming, and requires considerable expertise in the medical field
concerned. Secondly, medical guidelines are very detailed. Making sure that all the
information contained in the guideline is complete for the guideline’s purpose, and based
on sound medical principles, is hard work. An example of a tiny portion of a guideline
is shown in Figure 1; it is part of the guideline for general practitioners about the
treatment of diabetes mellitus type 2. This guideline fragment is used in this paper as
a running example.
One way to use formal methods in the context of guidelines is to automatically verify
whether a medical guideline fulfills particular properties, such as whether it complies
with quality indicators as proposed by health-care professionals [MBtTvH02]. For ex-
ample, using particular patient assumptions such as that after treatment the levels of
a substance are dangerously high or low, it is possible to check whether this situation
does or does not violate the guideline. However, verifying the effects of treatment as
well as examining whether a developed medical guideline complies with global criteria,
such as that it avoids the prescription of redundant drugs, or the request of tests that
are superfluous, is difficult to impossible if only the guideline text is available. Thus,
the capability to check whether a guideline fulfills particular medical objectives may re-
quire the availability of more medical knowledge than is actually specified in a medical
guideline, i.e., background knowledge is required.
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Table 1: Used temporal operators; t stands for a time instance.
Notation Interpretation Formal semantics
Hϕ ϕ has always been true in the past t  Hϕ⇔ ∀t′ < t : t′  ϕ
Gϕ ϕ is true now and at all future times t  Gϕ⇔ ∀t′ ≥ t : t′  ϕ
2.2 Using Temporal Logic for Guideline Representation
As medical management is a time-oriented process, diagnostic and treatment actions
described in guidelines are performed in a temporal setting. It has been shown previously
that the step-wise, possibly iterative, execution of a guideline, such as the example in
Figure 1, can be described precisely by means of temporal logic [MBtTvH02]. This is a
modal logic, where relationships between worlds in the usual possible-world semantics
of modal logic is understood as time order, i.e., formulae are interpreted in a temporal
structure F = (T, <, I). We will assume that the progression in time is linear, i.e.,
< is a strict linear order. For the representation of the medical knowledge involved
it appeared to be sufficient to use rather abstract temporal operators, as proposed in
literature [Luc03]. The language of standard logic, with equality and unique names
assumption, is augmented with the modal operators G, H, P, and F, where the temporal
semantics of the first two operators is defined in Table 1. The last two operators are
simply defined in terms of the first two operators:
 Pϕ↔ ¬H¬ϕ (some time in the past)
 Fϕ↔ ¬G¬ϕ (some time in the future)
This logic offers the right abstraction level to cope with the nature of the temporal
knowledge in medical guidelines required for our purposes. However, more fine-grained
temporal operators can be added if needed. For a full axiomatisation of this logic, see
Ref. [Tur85].
3 Application to Medical Knowledge
It is assumed that two types of knowledge are involved in detecting the violation of good
medical practice:
• Knowledge concerning the (patho)physiological mechanisms underlying the dis-
ease, and the way treatment influences these mechanisms. The knowledge involved
could be causal in nature, and is an example of object-knowledge.
• Knowledge concerning good practice in treatment selection; this is meta-knowledge.
Below we present some ideas on how such knowledge may be formalised using temporal
logic (cf. [Luc95] for earlier work).
We are interested in the prescription of drugs, taking into account their mode of
action. Abstracting from the dynamics of their pharmacokinetics, which are normally
modelled using differential equations, this can be formalised in logic as follows:
(G d ∧ r) → G(m1 ∧ · · · ∧mn)
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where d is the name of a drug or possibly of a group of drugs indicated by a predicate
symbol (e.g. SU(x), where x is universally quantified and ‘SU’ stands for sulfonylurea
drugs, such as Tolbutamid), r is a (possibly negative or empty) requirement for the drug
to take effect, and mk is a mode of action, such as decrease of release of glucose from
the liver, which holds at all future times.
The modes of action mk can be combined, together with an intention n (achieving
normoglycaemia, i.e., normal blood glucose levels, for example), a particular patient
condition c, and requirements rj for the modes of action to be effective:
(Gmi1 ∧ · · · ∧ Gmim ∧ r1 ∧ · · · ∧ rp ∧ Hc) → Gn
In both formulas the antecedent is strong. For example, a drug should always be applied
to conclude that a certain mode of actions occurs. In a strict sense, this formulation is
unrealistic, but the idea is that the time points that the modalities refer to are finite and
refers to the relevant information about the patient’s disease. This imprecise information
is enough to be able to verify a number of quality criteria, which will be shown below.
Good practice medicine can then be formalised as follows. Let B be background
knowledge, T ⊆ {d1, . . . , dp} be a set of drugs, C a collection of patient conditions, R a
collection of requirements, and N a collection of intentions which the physician has to
achieve. A set of drugs T is a treatment according to the theory of abductive reasoning
if [Poo90, Luc97]:
(M1) B ∪ GT ∪ C ∪R 2 ⊥ (the drugs do not have contradictory effects), and
(M2) B ∪ GT ∪ C ∪ R  N (the drugs handle all the patient problems intended to be
managed)
If in addition to (1) and (2) condition
(M3) Oϕ(T ) holds, where Oϕ is a meta-predicate standing for an optimality criterion
or combination of optimality criteria ϕ,
then the treatment is said to be in accordance with good-practice medicine. A typical
example of this is subset minimality O⊂:
O⊂(T ) ≡ ∀T
′ ⊂ T : T ′ is not a treatment according to (1) and (2)
i.e., the minimum number of effective drugs are being prescribed. For example, if
{d1, d2, d3} is a treatment that satisfies condition (3) in addition to (1) and (2), then the
subsets {d1, d2}, {d2, d3}, {d1}, and so on, do not satisfy conditions (1) and (2). In the
context of abductive reasoning, subset minimality is often used in order to distinguish
between various solutions; it is also referred to in literature as Occam’s razor. Another
definition of the meta-predicate Oϕ is in terms of minimal cost Oc:
Oc(T ) ≡ ∀T
′,with T ′ a treatment: c(T ′) ≥ c(T )
where c(T ) =
∑
d∈T cost(d); combining the two definitions also makes sense. For ex-
ample, one could come up with a definition of O⊂,c that among two subset-minimal
treatments selects the one that is the cheapest in financial or ethical sense.
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(2) Biguanides (BG)
(4) Insulin
(3) alpha−Glucosidase
inhibitors
(1) Sulfonylureas (SU)
Insulin
IntestinesLangerhans islets
Pancreas
Muscles
Liver
Figure 2: Summary of drugs and mechanisms controlling the blood level of glucose; −
− →: inhibition, · · · · · ·→: stimulation.
4 Management of Diabetes Mellitus Type 2
4.1 Diabetes Type 2 Background Knowledge
It is well known that diabetes type 2 is a very complicated disease. Here we focus on the
derangement of glucose metabolism in diabetic patients; however, even that is nontrivial.
To support non-expert medical doctors in the management of this complicated disease
in patients, access to a guideline is really essential.
One would expect that as this disorder is so complicated, the diabetes mellitus type
2 guideline is also complicated. This, however, is not the case, as may already be
apparent from the guideline fragment shown in Figure 1. This indicates that much of
the knowledge concerning diabetes mellitus type 2 is missing from the guideline, and
that without this background knowledge it will be impossible to spot the sort of flaws
we are after. Thus, the conclusion is that a deeper biological analysis is required, the
results of which are presented below.
Figure 2 summarises the most important mechanisms and drugs involved in the
control of the blood level of glucose. The protein hormone insulin, which is produced
by the B cells in the Langerhans islets of the pancreas, has the following major effects:
• it increases the uptake of glucose by the liver, where it is stored as glycogen, and
inhibits the release of glucose from the liver;
• it increases the uptake of glucose by insulin-dependent tissues, such as muscle and
adipose tissue.
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At some stage in the natural history of diabetes mellitus type 2, the level of glucose in
the blood is too high (hyperglycaemia) due to the decreased production of insulin by
the B cells.
Treatment of diabetes type 2 consists of:
• Use of sulfonylurea (SU) drugs, such as tolbutamid. These drugs stimulate the B
cells in producing more insulin, and if the cells are not completely exhausted, the
hyperglycaemia can thus be reverted to normoglycaemia (normal blood glucose
levels).
• Use of biguanides (BG), such as metformin. These drugs inhibit the release of
glucose from the liver.
• Use of α-glucosidase inhibitors. These drugs inhibit (or delay) the absorption of
glucose from the intestines. We omit considering these drugs in the following, as
they are only prescribed when treatment side-effects occur.
• Injection of insulin. This is the ultimate, causal treatment.
The background knowledge concerning the (patho)physiology of the glucose metabolism
as summarised above is formalised using temporal logic, and kept as simple as possible.
The specification is denoted by BDM2:
(1) GDrug(insulin) → G(uptake(liver, glucose) = up ∧
uptake(peripheral-tissues, glucose) = up)
(2) G(uptake(liver, glucose) = up → release(liver, glucose) = down)
(3) (GDrug(SU) ∧ ¬capacity(B-cells, insulin) = exhausted) →
Gsecretion(B-cells, insulin) = up
(4) GDrug(BG) → Grelease(liver, glucose) = down
(5) (Gsecretion(B-cell, insulin) = up ∧
capacity(B-cells, insulin) = subnormal ∧
QI ≤ 27 ∧ H Condition(hyperglycaemia))
→ GCondition(normoglycaemia)
(6) (Grelease(liver, glucose) = down ∧
capacity(B-cells, insulin) = subnormal ∧
QI > 27 ∧ H Condition(hyperglycaemia))
→ GCondition(normoglycaemia)
(7) ((Grelease(liver, glucose) = down ∨
Guptake(peripheral-tissues, glucose) = up) ∧
capacity(B-cells, insulin) = nearly-exhausted ∧
Gsecretion(B-cells, insulin) = up ∧
HCondition(hyperglycaemia))
→ GCondition(normoglycaemia)
(8) (Guptake(liver, glucose) = up ∧
Guptake(peripheral-tissues, glucose) = up) ∧
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capacity(B-cells, insulin) = exhausted ∧
HCondition(hyperglycaemia))
→ G(Condition(normoglycaemia) ∨Condition(hypoglycaemia))
(9) (Condition(normoglycaemia) ⊕ Condition(hypoglycaemia) ⊕
Condition(hyperglycaemia)) ∧ ¬(Condition(normoglycaemia) ∧
Condition(hypoglycaemia) ∧ Condition(hyperglycaemia))
where⊕ stands for the exclusive OR. Note that when the B-cells are exhausted, increased
uptake of glucose by the tissues may result not only in normoglycaemia but also in
hypoglycaemia (something not mentioned in the guideline).
4.2 Quality Check
As insulin can only be administered by injection, in contrast to the other drugs which
are normally taken orally, doctors prefer to delay prescribing insulin as long as possible.
Thus, the treatment part of the diabetes type 2 guideline mentions that one should start
with prescribing oral antidiabetics (SU or BG, cf. Figure 1). Two of these can also be
combined if taking only one has insufficient glucose-level lowering effect. If treatment
is still unsatisfactory, the guideline suggests to: (1) either add insulin, or (2) stop with
the oral antidiabetics entirely and to start with insulin.
The consequences of various treatment options were examined using the method
introduced in Section 3. Hypothetical patients for whom it is the intention to reach a
normal level of glucose in the blood (normoglycaemia) are considered, and treatment is
selected according to the guideline fragments given in Figure 1:
• Consider a patient with hyperglycaemia due to nearly exhausted B-cells:
BDM2 ∪ GT ∪ {capacity(B-cells, insulin) = nearly-exhausted} ∪
{H Condition(hyperglycaemia)}  GCondition(normoglycaemia)
holds for T = {Drug(SU),Drug(BG)}, which also satisfies the minimality condi-
tion O⊂(T ).
• Prescription of treatment T = {Drug(SU),Drug(BG),Drug(insulin)} for a patient
with exhausted B-cells, as is suggested by the guideline, yields:
BDM2 ∪ GT ∪ {capacity(B-cells, insulin) = exhausted} ∪
{H Condition(hyperglycaemia)} 
G(Condition(normoglycaemia) ∨ Condition(hypoglycaemia))
In the last case, it appears that it is possible that a patient develops hypoglycaemia due
to treatment; if this possibility is excluded from axiom (8) in the background knowledge,
then the minimality condition O⊂(T ), and also O⊂,c(T ), do not hold since insulin by
itself is enough to reach normoglycaemia. In either case, good practice medicine is
violated, which is to prescribe as few drugs as possible, taking into account costs and
side-effects of drugs. Here, three drugs are prescribed whereas only two should have
been prescribed (BG and insulin, assuming that insulin alone is too costly), and the
possible occurrence of hypoglycaemia should have been prevented.
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Figure 3: Translation of medical knowledge.
5 Automated Proving of Quality Requirements
As said in the introduction, we have explored the feasibility of using the automated
reasoning tools otter and mace-2 to check the quality of guidelines, in the sense as
described above.
5.1 Motivation for the Theorem Proving Facilities
One of the most important application areas of model finders and theorem provers
is program verification. Of course, with programs there is a clear beginning of the
execution, which makes it intuitive to think about properties that occur after the start
of the program. Therefore, it is not surprising much work has been done in the context
of model finding and theorem proving with only the future time modality. However, it is
more natural to model medical knowledge with past time operators, i.e., what happened
to the patient in the past. It is well-known that formulas with a past-time modality
can be mapped to a logical formula with only future time modalities such that both
formulas are equivalent for some initial state [Gab89]. However, the main drawback
to this approach is the fact that formulas will get much larger in size [Mar03] and as
a consequence become much harder to verify in a theorem prover designed for modal
logics.
For this reason, we have chosen to use an alternative approach which uses a relational
translation to map the temporal logic formulas to first-order logic. As primary tools we
use the resolution-based theorem prover otter and the finite model searcher mace-2,
which take first-order logic with equality as their input. There has been work done to im-
prove the speed of resolution-based theorem provers on modal formulas [AGHdR00], but
again, converse modalities such as the past-time operators are not considered. Nonethe-
less, we found that the general heuristics applicable to full first order logic are sufficient
for our task
To clarify our approach, see Figure 3. We will first give a definition for translating the
object knowledge to standard logic and then the translation of the meta-level knowledge
will follow.
9
5.2 Translation
5.2.1 Translation of Object Knowledge
We assume that the formalisation is in propositional temporal logic. We do this by
introducing a fresh proposition p for every equation that we find in the background
knowledge. For functions with two elements in the co-domain, we have p and ¬p and
for the capacity function with three elements in its co-domain, we add a proposition
px for each atom capacity(B-cells, insulin) = x and the appropriate axiomatisation such
that exactly one px holds. Technically this is not required, since we could extend the
translation below to full first-order temporal logic. In practice however, we would like to
avoid additional complexity from first-order formulas during the automated reasoning.
The relational translation (e.g., [Moo79, AGHdR00, SH03]) STt(ϕ), also referred to
as standard translation, translates a propositional temporal logical formula ϕ into a
formula in a first-order logic with a (time-indexed) unary predicate symbols P for every
propositional variable p and one binary predicate >. It is defined as follows, where t is
an individual variable:
STt(p) ⇔ P (t)
STt(¬ϕ) ⇔ ¬STt(ϕ)
STt(ϕ ∧ ψ) ⇔ STt(ϕ) ∧ STt(ψ)
STt(Gϕ) ⇔ ∀t′ : (t 6> t
′ → STt′(ϕ))
STt(Hϕ) ⇔ ∀t′ : (t > t
′ → STt′(ϕ))
Note that in our notation ∪ is sometimes used instead of a conjunction, so STt(Γ∪∆) is
defined as STt(Γ)∪ STt(∆). Note that the last two elements of the definition define the
meaning of the G modality and its converse, the H modality. For example, the formula
G(p→ Pp) translates to ∀t2(t 6> t2 → (P (t2) → ∃t3(t2 > t3 ∧ P (t3))). It is easy to show
that a formula in temporal logic is satisfiable if and only if its relational translation is.
In the literature a functional approach to translating modal logic has appeared as
well [Ohl88], which relies on a non-standard interpretation of modal logic and could be
taken as an alternative to this translation.
5.2.2 Translation of Meta-level Knowledge
Again, we consider the criteria for good practice medicine and make them suitable for
the automated reasoning tools. We say that a treatment T is a treatment complying
with requirements of good practice medicine iff:
(M1′) STt(B ∪ GT ∪C ∪R) 0 ⊥
(M2′) STt(B ∪ GT ∪C ∪R ∪ ¬N) ` ⊥
(M3′) ∀T ′ ⊂ T : T ′ is not a treatment according to (1) and (2)
It is easy to see that, because the relational translation preserves satisfiability, these
quality requirements are equivalent to their unprimed counterparts. To automate this
reasoning process we use mace-2 to verify (M1′), otter to verify (M2′), and (M3′)
can be seen as a combination of both for all subsets of the given treatment.
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5.3 Proofs
In this subsection we will discuss the actual implementation in otter [McC03] and
some results by using various heuristics.
5.3.1 Resolution Strategies
The main advantage that one gains from using a standard theorem prover is the fact that
a whole range of different resolution rules are available. Note that Otter uses the set-
of-support strategy [WRC65] as a standard strategy. With this strategy the original set
of clauses is divided into a set-of-support and a usable set such that in every resolution
step at least one of the parent clauses has to be member of the set-of-support and each
resulting resolvent is added to the set-of-support.
Looking at the structure of the formulas in Section 4, one can see that formulas are
of the type p0 ∧ . . . ∧ pn → q, where p0 ∧ . . . ∧ pn and q are all positive literals. Hence,
we expect mostly negative literals in our clauses, which was exploited by using negative
hyperresolution in otter. With this strategy a clause with at least one positive literal
is resolved with a number of clauses which only contain negative literals (i.e., negative
clauses), provided that the resolvent is a negative clause. The parent clause with at least
one positive literal is called the nucleus, and the other, negative, clauses are referred to as
the satellites. Positive hyperresolution, which uses positive satellites and a nucleus with
at least one negative literal, was also tried. However, this did not result in successful
proofs, because the background knowledge contains few positive clauses.
5.3.2 Verification
The ordering predicate > that was introduced in Section 5.2.1 was defined by anti-
reflexivity, anti-symmetry, and transitivity. We did not find any cases where the axiom
of transitivity was required to construct the proof, which can be explained by the low
modal depth of our formulas. As a consequence, the axiom was omitted with the aim
to improve the speed of theorem proving.
We used otter to perform the two proofs which are instantiations of (M2′). First
we, again, consider a patient with hyperglycaemia due to nearly exhausted B-cells and
prove:
ST0(BDM2 ∪ GT ∪ {capacity(B-cells, insulin) = nearly-exhausted} ∪
{H Condition(hyperglycaemia)} ∪ {¬GCondition(normoglycaemia)}) ` ⊥
where T = {Drug(SU),Drug(BG)},
This property was proven with otter in 62 resolution steps with the use of the
negative hyperresolution strategy. As an example, we present a small snippet from the
proof of this property. We will use the same syntax as we used in the previous sections,
but each literal is augmented with a time-index. Note that g(x, y) = down is imple-
mented as a negative literal and functions f1 and f2 are Skolem functions introduced
by otter. Both Skolem functions map a time point to a later time points. Consider
the following clauses in the usable and set-of-support list. For example, assumption
(53) models the capacity of the B-cells, i.e., nearly exhausted at time t = 0 where the
property as shown above should be refuted:
11
2 capacity(B-cells, insulin, t0) 6= nearly-exhausted ∨
capacity(B-cells, insulin, t0) 6= exhausted
14 t0 6> f1(t0) ∨ capacity(B-cells, insulin, t0) = exhausted ∨ t0 > t1∨
secretion(B-cells, insulin, t1) = up
15 ¬Drug(SU) ∨ capacity(B-cells, insulin, t0) = exhausted ∨ t0 > t1∨
secretion(B-cells, insulin, t1) = up}
51 0 > t0 ∨Drug(SU, t0)
53 capacity(B-cells, insulin, 0) = nearly-exhausted
Very early in the proof, otter deduces that if the capacity of insulin in B-cells is
nearly-exhausted, then it is not completely exhausted:
56 [neg hyper,53,2] capacity(B-cells, insulin, 0) 6= exhausted
Now we skip a part of the proof, which results in information about the relation between
the capacity of insulin and the secretion of insulin in B-cells for a certain time point:
517 [neg hyper,516,53] 0 6> f2(0)
765 [neg hyper,761,50,675] capacity(B-cells, insulin, f2(0)) 6= nearly-exhausted ∨
secretion(B-cells, insulin, f2(0)) = down
This information allows otter to quickly complete the proof, by combining it with the
information about the effects of a sulfonylurea drug:
766 [neg hyper,765,15,56,517] capacity(B-cells, insulin, f1(0)) 6= nearly-exhausted ∨
¬Drug(SU)
767 [neg hyper,765,14,56,517] capacity(B-cells, insulin, f1(0)) 6= nearly-exhausted ∨
0 6> f1(0)
after which (53) can be used as a nucleus to yield:
768 [neg hyper,767,53] 0 6> f1(0)
and consequently by taking (51) as a nucleus, we find that at time point 0 the capacity
of insulin is not nearly exhausted:
769 [neg hyper,768,51,766] capacity(B-cells, insulin, 0) 6= nearly-exhausted
This directly contradicts one of the assumptions and this results in an empty clause:
770 [binary,769.1,53.1] ⊥
Similarly, we could prove that given a treatment T = {Drug(SU),Drug(BG),Drug(insulin)}
for a patient with exhausted B-cells, as is suggested by the guideline, it follows that:
ST0(BDM2 ∪ GT ∪ {capacity(B-cells, insulin) = exhausted} ∪
{HCondition(hyperglycaemia)} ∪
{¬(G(Condition(normoglycaemia) ∨ Condition(hypoglycaemia)))}) ` ⊥
The proof of otter is omitted, but a similar magnitude of complexity in the proof
can be observed, i.e., 52 resolution steps.
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Weights Clauses (binary res) Clauses (negative hyper res)
(0, 1) 17729 6994
(1, 0) 13255 6805
(1, 1) 39444 7001
(1,−1) 13907 6836
(2,−2) 40548 7001
(2,−3) 16606 6805
(3,−4) 40356 7095
(3,−5) 27478 7001
Figure 4: Generated clauses to prove an instance of property M2′ depending on weights
(x, y) for the ordering relation on time.
5.3.3 Weighing the Clauses
In this section we consider the weighing facilities as offered by otter to improve the
performance. Consider the example from [AGHdR00]. Suppose we have the formula
G(p → Fp). Proving this satisfiable amounts to proving that the following two clauses
are satisfiable:
1. c > t1 ∨ ¬P (t1) ∨ t1 6> f(t1)
2. c > t2 ∨ ¬P (t2) ∨ P (f(t2))
The observation can be made, that although we have two possibilities to resolve
these two clauses, for example on the P literal, this is useless because the negative P
literal is only bound by the G-operator while the positive P literal comes from a formula
at a deeper modal depth under the F-operator. Suppose we resolve these two P literals,
which generates the clause:
c > f(t) ∨ f(t) 6> f(f(t)) ∨ c > t ∨ ¬P (t)
and with (2) again we have:
c > f(f(t)) ∨ f(f(t)) 6> f(f(f(t))) ∨ c > f(t) ∨ c > t ∨ ¬P (t)
etc.
So we can see that we can generate a lot of new clauses, but clearly these nestings
of the Skolem functions will not lead to a contradiction very quickly if the depth of the
modalities in the formulas that we have is small.
In otter the weight of the clauses determines which clauses are chosen from the
set-of-support and usable list to become parents in a resolution step. Clearly, because
the goal of resolution is to find an empty clause, lighter clauses are preferred. By default,
the weight of a clause is the sum of all occuring symbols (i.e., all symbols have weight
1), but as we have argued, the nesting of Skolem functions will not help to find such an
empty clauses. Therefore it can be of use to manually change the weight of the ordering
symbol, which is done in otter by a tuple (x, y) for each predicate, where x is multiplied
with sum of the weight of its arguments and is added to y to calculate the new weight
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> : Condition(hyperglycaemia) :
| 0 1 0 1
--+---- -------
0 | F T T T
1 | F F
Figure 5: Snippet from a mace-2 generated model
of this predicate. For example, if x = 2 and y = −3, then x > y has a total weight of
2+2−3 = 1, while f(f(x)) > f(y) has a weight of 2∗3+2∗2−3 = 7. See Figure 4 where
we show results when we applied this for some small values for x and y for both binary
and negative hyperresolution. What these numbers tend to show (similar numbers were
gained from the other property) is that the total weight of the ordering predicate should
be smaller than the average weight of other, unary, predicates. Nonetheless, possibly
somewhat suprisingly, the factor x should not be raised too much, although in the case
of a negative hyperresolution strategy the effect is minimal. Furthermore, we can see
that combining the resolution strategies with a weighing strategy does help, but the
advantages are rather limited compared to the advantages of weighing in combination
with binary resolution.
5.4 Disproofs
mace-2 (Models And CounterExamples) [McC01] is a program that searches for small
finite models of first-order statements using a David-Putman-Loveland-Logemann de-
cision procedure [DP69, DLL62] as its core. Because of the relative simplicity of our
temporal formulas, it is to be expected that counterexamples can be found with very
few states. Hence, it can be expected that models are in the same magnitude as the
propositional case and this is indeed the case. In fact, the countermodels that mace-2
found consist of only 2 elements in the domain of the model.
The first property we check corresponds to checking if the background knowledge
augmented with a patient and a therapy is consistent, i.e., criterium (M1′). So, again
consider a patient with hyperglycaemia due to nearly exhausted B-cells. We have used
mace-2 to verify:
ST0(BDM2 ∪ G T ∪ {capacity(B-cells, insulin) = exhausted} ∪
{H Condition(hyperglycaemia)}) 0 ⊥
for T = {Drug(SU),Drug(BG),Drug(insulin)}. From this, of course, it follows that there
is a model if T = {Drug(SU),Drug(BG)} and consequently we have verified (M1′).
Similarly, we find that for all T ⊂ {Drug(SU),Drug(BG)}, it holds that:
ST0(BDM2 ∪ GT ∪ {capacity(B-cells, insulin) = nearly-exhausted} ∪
{H Condition(hyperglycaemia)} ∪ {¬GCondition(normoglycaemia)}) 0 ⊥
So indeed the conclusion is that the treatment complies with (M3′) and thus com-
plies with the criteria of good practice medicine. See for example Figure 5, which
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contains a small sample of the output that mace-2 generated. The output is a first-
order model with two elements in the domain named ‘0’ and ‘1’ with an interpretation
of all predicates and functions to this domain. It shows that it is consistent with the
background knowledge to believe that the patient will continue to suffer from hyper-
glycaemia if one of the drugs is not applied. It is interesting to see that there is also a
smaller model where the size of the domain is 1 for this set of formulas.
Finally, consider the treatment T = {Drug(SU),Drug(BG),Drug(insulin)} for a pa-
tient with exhausted B-cells, and suppose we exclude the patient developing hypogly-
caemia, we can show that:
ST0(BDM2 ∪ GT ∪ {capacity(B-cells, insulin) = exhausted} ∪
{HCondition(hyperglycaemia)} ∪
{¬G(Condition(hyperglycaemia)} ∪ {¬G(Condition(hypoglycaemia)))}) 0 ⊥
But, it is possible to prove the same property if T = {Drug(insulin)} and thus (M3 ′)
does not hold in this case and as a consequence the guideline does not comply with the
quality requirements as discussed in the previous section.
6 Discussion
The quality of guideline design is for the largest part based on its compliance with spe-
cific treatment aims and global requirements. To this purpose, use was made of the
theory of abductive, diagnostic reasoning, i.e., we diagnosed potential problems with a
guideline using logical abduction [Luc97, Luc03, Poo90]. This is a meta-level character-
isation of the quality of a medical guideline. What was diagnosed were problems in the
relationship between medical knowledge, suggested treatment actions in the guideline
text and treatment effects; this is different from traditional abductive diagnosis, where
observed findings are explained in terms of diagnostic hypotheses. This method allows
us to examine fragments of a guideline and to prove properties of those fragments.
In earlier work [HLB04], where we used a tool for interactive program verification
named KIV [Rei95], we performed a similar exercise. The main advantage of using
interactive theorem proving is that the resulting proof is relatively elegant compared to
automated resolution-based solutions. This might be important if one wants to convince
the medical community that a guideline complies with their medical quality requirements
and to promote the implementation of such a guideline. However, to support the design
of guidelines, this argument is of less importance. Moreover, the work that needs to be
done to construct a proof in an interactive theorem prover would severely slow down
the development process as people with specialised knowledge are required.
Even though guideline developers might not be interested in inspecting the full proof
or disproof of a certain property, it is of importance for the process that if a certain
proof fails, they have a method to find out why the proof failed. Thus in our future work
we will focus on the question whether it is possible to give hints to guideline developers
on how to improve their guidelines. Furthermore, our quality requirements are far from
exhaustive and the last few years research has been done in this field (e.g. [FAB+04]).
Our aim will be to extend our current work with these new insights.
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In this paper, we have made use of tools designed for automated reasoning to actu-
ally quality check a medical guideline using the theory of quality of guidelines developed
previously [Luc03]. This complements both the earlier work on object-level verification
of medical guidelines using the interactive theorem prover designed for program verifi-
cation KIV [MBtTvH02], but also our earlier work where we used KIV for meta-level
reasoning [HLB04].
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